Classifying drug-resistant epilepsy and assessing risk: separate seizure type, syndrome, cause, and treatment response

Drug-resistant epilepsy does not progress through a universal stage-one-to-stage-four system. Clinicians describe seizures, epilepsy type, syndrome, cause, and treatment response, then assess risks such as injury, status epilepticus, and cognitive or other difficulties. Understanding these layers helps explain why people given the same drug-resistant label may discuss very different treatment options. Scheffer et al.: ILAE classification of the epilepsies, 2017NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

A person may have frequent events or an infrequent seizure with serious consequences. Drug resistance concerns failure to maintain seizure freedom after adequate, correctly used, suitable and tolerated medication schedules. It is not established solely by frequency, duration of the illness, or how dramatic the movements appear. ILAE: Drug-Resistant Epilepsy, definition and clinical resources NINDS: Epilepsy and Seizures
Structural, genetic, infectious, metabolic, immune, and unknown causes form important etiologic categories. A patient may have both genetic and structural factors without contradiction. Structural evidence may matter to surgical assessment, while genetic interpretation can inform family counseling and selected treatment discussions. Scheffer et al.: ILAE classification of the epilepsies, 2017
Provide the receiving epilepsy specialist with a brief timeline from onset, descriptions of each event type, medication trials, and original EEG and imaging. CAAE center information can help identify an assessment route, but verify the appropriate age-group expertise and multidisciplinary service rather than relying only on an institution's name. 中国抗癫痫协会：第五批一、二级癫痫中心评审结果，2025年9月28日

Quick answer

Drug-resistant epilepsy does not progress through a universal stage-one-to-stage-four system. Clinicians describe seizures, epilepsy type, syndrome, cause, and treatment response, then assess risks such as injury, status epilepticus, and cognitive or other difficulties. Understanding these layers helps explain why people given the same drug-resistant label may discuss very different treatment options. Scheffer et al.: ILAE classification of the epilepsies, 2017 NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025

Full guide

Drug-resistant epilepsy does not progress through a universal stage-one-to-stage-four system. Clinicians describe seizures, epilepsy type, syndrome, cause, and treatment response, then assess risks such as injury, status epilepticus, and cognitive or other difficulties. Understanding these layers helps explain why people given the same drug-resistant label may discuss very different treatment options. Scheffer et al.: ILAE classification of the epilepsies, 2017 NICE NG217: Terms used, drug-resistant epilepsy definition, updated January 2025

Drug resistance does not describe one outward seizure pattern

A person may have frequent events or an infrequent seizure with serious consequences. Drug resistance concerns failure to maintain seizure freedom after adequate, correctly used, suitable and tolerated medication schedules. It is not established solely by frequency, duration of the illness, or how dramatic the movements appear. ILAE: Drug-Resistant Epilepsy, definition and clinical resources NINDS: Epilepsy and Seizures

Brief events affecting consciousness deserve documentation as well as convulsions. Conversely, a first bilateral convulsion does not automatically establish drug-resistant epilepsy. The clinician needs to identify the event and review prior treatment. Patients should not feel that they must emphasize only the most spectacular episode to have their difficulties taken seriously.

First describe what happens during an individual seizure

The 2025 ILAE seizure classification includes focal, generalized, unknown whether focal or generalized, and unclassified categories. It uses available evidence about the seizure and adds descriptions of how manifestations evolve. A smell, abdominal sensation, behavioral pause, or one-sided movement followed by other changes can provide useful chronological information. ILAE: Updated classification of epileptic seizures, 2025

Use ordinary language if necessary. Explain whether the person responded, what they later remembered, and whether speech difficulty persisted. This can be more helpful than saying simply conscious or unconscious. The updated classification considers both awareness and responsiveness; if one was not assessed during the event, say so. Beniczky et al.: Updated seizure classification, ILAE position paper, Epilepsia 2025

The description should not be rewritten to fit a suspected label. Preserve what actually happened, including uncertainty about the first moments. A specialist can then decide how confidently the event can be classified.

A focal seizure does not have to remain on one side of the body

Focal seizures can develop into bilateral tonic-clonic activity. The final appearance of whole-body convulsions does not by itself establish generalized epilepsy. An initial sensation or behavioral change may be overlooked because later movements draw more attention. Beniczky et al.: Updated seizure classification, ILAE position paper, Epilepsia 2025

Evidence of focality influences medication and presurgical assessment, but a one-sided observation is not a direct surgical map. Clinical, EEG, and imaging findings need to support the interpretation. The regions involved as a seizure spreads are not necessarily identical to the tissue that would need treatment. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022

Generalized seizures include more than convulsions

Absence, myoclonic, and tonic-clonic seizures are among the different generalized patterns. Their syndrome context and management can differ. Not every stare is an absence seizure, and not every brief morning jerk should automatically be dismissed as tiredness. The details and appropriate investigations matter. ILAE: Updated classification of epileptic seizures, 2025 NICE NG217: Diagnosis and assessment of epilepsy

Classification has practical implications because a medicine useful for one type may aggravate particular events in another syndrome. Report every event pattern before a medication change. Otherwise, treatment may appear to address the most visible seizure while a less obvious but important type is missed. Wu et al.: Clinical practice guidelines for third-generation antiseizure medications, Seizure 2026;134:13–26

The person's epilepsy type is a second level of description

Epilepsy type is not simply the name of one observed seizure. The ILAE framework includes focal, generalized, combined generalized and focal, and unknown epilepsy. Evidence for more than one class can reflect the patient's overall disorder rather than an error in the records. Scheffer et al.: ILAE classification of the epilepsies, 2017

This epilepsy-level framework and the updated 2025 seizure classification address different layers. Combined generalized and focal epilepsy should not be translated as unclassifiable, and older seizure terminology should not prompt an independent prescription change. Ask how the event-level and epilepsy-level descriptions relate in the patient's case.

An uncertain classification can remain clinically useful if its limits are clear. The clinician can choose an appropriate next investigation or treatment strategy while avoiding an unsupported label. Certainty should increase with evidence rather than with the number of times a diagnosis has been copied into a record.

A syndrome combines several characteristic features

A syndrome is generally identified from age at onset, seizure combinations, EEG, developmental course, and sometimes characteristic causes. It can guide treatment and attention to associated problems, but not every person with epilepsy fits a named syndrome. An unnamed syndrome does not mean that useful treatment must stop. ILAE: Introduction to the epilepsy syndrome position papers, 2022

In children, the interpretation may evolve as development and new event patterns become apparent. Preserve early histories, videos, and EEG findings. Adults who did not have specialist assessment in childhood may also benefit from a careful reconstruction of that earlier course.

Dravet and Lennox-Gastaut illustrate different care needs

Dravet syndrome commonly has a characteristic course beginning in infancy, with later seizure and developmental features. Diagnosis requires the full electroclinical assessment. Some medicines commonly used for focal epilepsy may be unsuitable in typical Dravet circumstances, so the plan should be reviewed by clinicians familiar with the syndrome. ILAE EpilepsyDiagnosis: Dravet syndrome overview NINDS: Dravet Syndrome

Lennox-Gastaut syndrome involves characteristic seizure and EEG combinations. Falls, learning, behavior, and sleep may become important care concerns. Failure of multiple medicines or a positive genetic result alone does not establish LGS. The team needs the complete pattern to distinguish a syndrome description from the underlying cause. ILAE EpilepsyDiagnosis: Lennox-Gastaut syndrome overview

These names should help organize care, not replace individual assessment. Patients sharing a syndrome can still differ in age, dominant seizure burden, organ health, and treatment tolerance. A syndrome-specific option is a reason for an informed discussion rather than an automatic prescription.

Etiology can occupy more than one category

Structural, genetic, infectious, metabolic, immune, and unknown causes form important etiologic categories. A patient may have both genetic and structural factors without contradiction. Structural evidence may matter to surgical assessment, while genetic interpretation can inform family counseling and selected treatment discussions. Scheffer et al.: ILAE classification of the epilepsies, 2017

Genetic does not necessarily mean inherited from a parent, and structural does not necessarily mean tumor. A proposed cause still needs to fit the clinical picture. Unknown means that current evidence has not identified an explanation; it does not make the symptoms unreal or prove that future investigation can never add information. Krey et al.: Current practice in diagnostic genetic testing of the epilepsies, ILAE Genetics Commission, 2022 ILAE EpilepsyDiagnosis: Structural etiologies and imaging

Ask which part of care the etiologic finding changes. For some patients it affects treatment directly; for others it provides counseling or surveillance information. A cause can be meaningful even when it does not lead to a new targeted medicine.

Rapid deterioration requires a different response from routine chronic review

Recently escalating seizures with new memory, behavioral, psychiatric, or consciousness changes may require investigation for encephalitis and other acute causes. The immediate issue extends beyond a long-term drug-resistant label. Antibodies, cerebrospinal fluid, imaging, and the clinical course need joint interpretation. Abboud et al.: Autoimmune encephalitis diagnosis and acute management best-practice recommendations, 2021

Drug-resistant epilepsy and refractory status epilepticus are not interchangeable expressions. The latter concerns an acute continuing seizure state and its response to emergency treatment. It should not be treated as merely another name for ordinary difficult epilepsy. Acute deterioration requires timely local care rather than waiting for a distant routine appointment.

Assess the consequences as well as the number of seizures

Two people with similar event frequency can have different risks. One may fall without warning while another mainly has brief sensory experiences. Impaired consciousness, occurrence during sleep, duration, injury, and ability to care for oneself during recovery all influence planning. Families can document these consequences alongside counts. NINDS: Epilepsy and Seizures

Swimming, heights, machinery, driving, and living arrangements require advice based on the individual's events and applicable local rules. This is not the same as a universal prohibition on exercise. Practical adjustments, informed companions, and an emergency response can improve safety while preserving participation where feasible.

The clinician should explain which risk is being addressed by each restriction. A recommendation tied to a clear concern is easier to follow and review than an indefinite instruction to avoid ordinary life. When control changes, the plan can be reassessed through the appropriate clinical and regulatory process.

Agree in advance how to respond to prolonged or clustered seizures

A convulsive seizure reaching five minutes or repeated seizures without recovery of consciousness needs emergency action. Someone with recognized clusters should have an individualized description of their pattern, prescribed rescue treatment when relevant, and criteria for calling for help. Another family's medicine dose should never be copied. NICE NG217: Full guideline, updated January 30, 2025

Protect the environment, time the event, and avoid putting objects in the mouth. Attend to breathing and injury. A first seizure, an event in water, or other dangerous circumstances may require earlier assistance. Before a visit to China, translate the existing plan and confirm how it can be implemented locally. CDC: First Aid for Seizures

Discuss SUDEP through individual factors and possible action

SUDEP risk should be explained in the patient's circumstances, with particular attention to uncontrolled tonic-clonic seizures. Medication use, improved seizure control, and appropriate night-time care are among the matters to discuss. One seizure label or EEG result cannot predict an individual's fate. NICE NG217: Reducing epilepsy-related death and SUDEP risk

Ask about sleeping alone, recognizing an event, and who would respond. Devices may assist but do not guarantee prevention. Planning should also respect privacy and independence. The aim is an informed, workable response to the person's actual risks rather than extreme restrictions unsupported by their situation.

Development, cognition, mood, and treatment burden are also relevant

Developmental impairment in a child may arise from both the underlying cause and epileptic activity. Fewer convulsions do not automatically guarantee complete developmental recovery. The concept of developmental and epileptic encephalopathy draws attention to the contribution of both processes. Serial observations of skills, learning, and behavior help the team assess the course. ILAE: Introduction to the epilepsy syndrome position papers, 2022

Adults can experience memory, mood, sleep, and multiple-medication effects. Neuropsychological assessment can establish a baseline and inform treatment risk, but its findings should be connected to daily functioning. The patient's valued abilities belong among treatment goals rather than allowing the seizure count to represent the entire outcome. Baxendale et al.: ILAE neuropsychological assessment in epilepsy surgery, 2019

Caregiver strain is also useful information for planning. A regimen requiring support that the household cannot maintain needs discussion. Reporting that difficulty allows the team to address practical care instead of assuming that a written recommendation is being carried out exactly.

Bring the layers together during a review in China

Provide the receiving epilepsy specialist with a brief timeline from onset, descriptions of each event type, medication trials, and original EEG and imaging. CAAE center information can help identify an assessment route, but verify the appropriate age-group expertise and multidisciplinary service rather than relying only on an institution's name. 中国抗癫痫协会：第五批一、二级癫痫中心评审结果，2025年9月28日

Ask the written conclusion to distinguish seizure type, epilepsy type, syndrome, etiology, and drug response, including uncertainty where it remains. Then connect the two or three most important risks to specific actions. Classification becomes clinically useful when it supports treatment selection, daily planning, and a handover that the clinician at home can understand.